| 1 | 13:30-13:40 |
Opening Remarks |
|
|||||||||||
| 1 | 13:40-13:55 |
Translational Medicine Empowering Drug Development |
|
||||||||||||||||||||||||||||||||||||||||||||
| 2 | 13:55-14:10 |
Urology Discipline Development and Operations Management at Renji Hospital |
|
||||||||||||||||||||||||||||||||||||||||||||
| 3 | 14:15-14:35 |
Patient-Centered Optimization and Practice of Multidisciplinary Team (MDT) Management in Urology |
|
||||||||||||||||||||||||||||||||||||||||||||
| 4 | 14:35-14:45 |
Discussion |
|
||||||||||||||||||||||||||||||||||||||||||||
| 1 | 14:45-15:05 |
New Advances in Global Uro-oncology Diagnosis and Treatment (2026) |
|
||||||||||||||||||||||||||||||||||||||
| 2 | 15:05-15:25 |
New Breakthroughs in Precision Diagnosis and Treatment for mHSPC Prostate Cancer |
|
||||||||||||||||||||||||||||||||||||||
| 3 | 15:25-15:35 |
Discussion |
|
||||||||||||||||||||||||||||||||||||||
| 1 | 15:35-15:40 |
Summary |
|
|||||||||||
| 1 | 15:50-15:55 |
Opening Remarks |
|
||||||||
| 1 | 15:55-16:20 |
Applications and Prospects of Urinary DNA Testing in the Whole-Course Management of Urothelial Carcinoma |
|
||||||||||||||
| 2 | 16:20-16:45 |
Real-World Data on Urinary DNA Testing |
|
||||||||||||||
| 3 | 16:45-17:05 |
Discussion1: How Can Urinary DNA Testing Be Integrated into the Whole-Course Management of Urothelial Carcinoma |
|
||||||||||||||
| 1 | 17:05-17:30 |
Evidence-Based Advances of PSMA PET in Precision Diagnosis and Treatment of Prostate Cancer: Staging Reassessment, Impact on Treatment Decisions, and the Trend toward Theranostics |
|
||||||||||||||
| 2 | 17:30-17:45 |
Discussion2: How Molecular Imaging Is Reshaping the Whole-Course Management Paradigm for Prostate Cancer |
|
||||||||||||||
| 1 | 17:45-17:50 |
Summary |
|
|||||